期刊文献+

包裹液态氟碳的高分子超声造影剂的制备及体外显影实验 被引量:11

Preparation of molecular polymer ultrasound contrast agents with liquid perfluorocarbons and in vitro experiment
下载PDF
导出
摘要 目的制备一种新型超声造影剂——液态氟碳高分子微球,观察其体外物理特性及超声、CT显影效果。方法采用乳化-蒸发法制备包裹液态氟碳的高分子微球;以光镜、扫描电镜观察微球形态、分布,以激光粒度和电位分析仪检测微球粒径、电位;DiI着色后,于荧光显微镜下观察微球结构和荧光强度;行体外超声和CT,观察其显影效果。结果所制备的液态氟碳高分子微球外观为乳白色混悬液,形态规则,呈球包球形;平均粒径为(413±32)nm,平均电位为(-2.42±5.71)mV;荧光染色后微球的乳酸/羟基乙酸共聚物(PLGA)外壳呈环形红色荧光,而内部包绕的液态氟碳不发光、呈黑色;体外超声与CT显影效果好。结论成功制备的液态氟碳高分子微球粒径小,稳定性好,体外可同时增强超声和CT,有望成为一种新型的多功能超声造影剂。 Objective To prepare a new type of ultrasound contrast agents polymeric microcapsules of liquid perfluorocarbons,and to observe its physical characteristics and effects on enhancing ultrasound and CT imaging in vitro.Methods Polymeric microcapsules of liquid perfluorocarbons were prepared by using emulsion solvent-evaporation process.The morphology and distribution were observed with optical and scanning electron microscope.The size and electric potential were obtained by using laser light scattering analyzer.DiI was added into the organic solution to observe the structure and fluorescence intensity of microcapsules.The enhancement effect in vitro was observed with ultrasound and CT imaging.Results The successfully prepared polymeric microcapsules of liquid perfluorocarbons was milky suspension in appearance,the size and distribution were highly uniformed with core-shell structure,with the mean size and average potential of(413± 32) nm and(-2.42±5.71) mV,respectively.Fluorescent microscopy images showed spherical capsules with a nice red shell and a darker core.The enhancement effects of ultrasound and CT imaging were good.Conclusion The polymeric microcapsules of liquid perfluorocarbons are successfully prepared and can enhance ultrasound and CT imaging in vitro,which may become a new type of multi-function ultrasound contrast agents.
出处 《中国介入影像与治疗学》 CSCD 2012年第4期291-294,共4页 Chinese Journal of Interventional Imaging and Therapy
基金 国家重点基础研究发展计划(973计划)项目(2011CB707900) 国家自然科学基金面上项目(30770566 30900371) 重庆高校优秀成果转化项目(Kjzh10201)
关键词 超声检查 液态氟碳 高分子聚合物 Ultrasonography Liquid perfluorocarbons High molecular polymer
  • 相关文献

参考文献12

  • 1Gross U,Rudiger S,Reichelt H. Perfluorocarbons:Chemically inert but biologically active[J].Journal of Fluorine Chemistry,1991,(02):155-161.
  • 2Wickline SA,Hughes M,Ngo FC. Blood contrast enhance ment with a novel,non-gaseous nanoparticle contrast agent[J].Academic Radiology,2002,(Suppl 2):S290-S293.
  • 3Beekman F,Mutton BF. Multi-modality imaging on track[J].European Journal of Nuclear Medicine and Molecular Imaging,2007,(09):1410-1414.
  • 4Beyer T,Pietrzyk U,Knoess C. Multi-modality imaging of uveal melanomas using combined PET/CT,high-resolution PET and MR imaging[J].Nuklearmedizin,2008,(02):73-79.
  • 5Rouse HC,Godoy MC,Lee WK. Imaging findings of unusual anorectal and perirectal pathology:A multi-modality approach[J].Clinical Radiology,2008,(12):1350-1360.doi:10.1016/j.crad.2008.06.008.
  • 6杨扬,王志刚,郑元义,郭大静,赵建农,李奥.液态氟碳纳米脂质微球超声对比剂用于增强正常大鼠CT显像实验研究[J].中国医学影像技术,2008,24(9):1341-1344. 被引量:25
  • 7李奥,王志刚.液态氟碳纳米粒——一种多功能影像学造影剂[J].临床超声医学杂志,2008,10(12):830-832. 被引量:15
  • 8Mattrey RF,Long DM,Multer F. Perfluoroctylbromide:A reticuloendothclial-specific and tumor-imaging agent for compu ted tomography[J].Radiology,1982,(03):755-758.
  • 9Young SW,Enzmann DR,Long DM. Perfluoroctylbromide contast enhancement of malignant neoplasms:Preliminary obser vations[J].American Journal of Roentgenology,1981,(01):141-146.
  • 10Liuand MS,Long DM. Perfluoroctylbromide as a diagnostic contrast medium in gastroenterography[J].Radiology,1977,(01):71-76.

二级参考文献42

  • 1冉海涛,任红,王志刚,郑元义,张群霞,李小东,许川山.一种新型高分子聚合材料微泡超声造影剂的制备与体外显影实验[J].中华超声影像学杂志,2005,14(10):774-776. 被引量:26
  • 2伍星,王志刚,许川山.纳米级造影剂在超声分子显像与靶向治疗中的研究进展[J].中华超声影像学杂志,2006,15(7):539-540. 被引量:13
  • 3张勇,王志刚,许川山.纳米抗体:一种潜力巨大的超声造影剂靶向分子[J].中华超声影像学杂志,2007,16(2):171-172. 被引量:4
  • 4Clark LC, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science, 1966, 152 (730) : 1755 - 1756.
  • 5Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol, 2003,28 (12) : 625 - 653.
  • 6Hughes MS, Marsh JN, Hall CS, et al. Acoustic characterization in whole blood and plasma of site - targeted nanopartiele ultrasound contrast agent for molecular imaging. Acoust Soc Am, 2005,117 (12) : 1964 - 1972.
  • 7Marsh JN,Hail CS,Scott MJ,et al. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model.IEEE Trans Ultrasan Ferroelectr Freq Control,2000,49(1) :29- 38.
  • 8Hall CS, Marsh JN, Scott M J, et al. Temperature dependence of ultrasonic enhancement with a site- targeted contrast agent. J Acoust Soc Am,2001, 110(3 Pt 1):1677-1684.
  • 9Marsh JN, Hall CS, Wickline SA, et al. Temperature dependence of acoustic impedance for specific fluorocarbon liquids. J Acoust Soc Am, 2002,112(6) :2858 - 2862.
  • 10Marsh JN, Partlow KC, Abendschein DR, et al. Molecular imaging with targted prefluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound in Med & Biol,2007,33(6):950- 958.

共引文献44

同被引文献166

  • 1徐亚丽,高云华.超声介导造影微泡在炎症靶向方面的研究进展[J].中华超声影像学杂志,2005,14(4):310-312. 被引量:3
  • 2Kaneda MM, Caruthers S, Lanza GM, et al. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Ann Biomed Eng, 2009,37(10):1922-1933.
  • 3Kornmann LM, Curls I)M, Hermeling E, et al. Perfluorohexane- loaded macrophages as a novel ultrasound contrast agent : A feasi- bility study. Mol Imaging Biol, 2008, 10(5):264 270.
  • 4Saha P, Modarai B, Humphries J, et al. The monocyte/macro- phage as a therapeutic target in atherosclerosis. Curr Opin Phar- macol, 2009,9(2) : 109-118.
  • 5Schad KC, Hynynen K: In vitro characterization of perfluorocar- bon droplets for focused ultrasound therapy. P hys Med Biol, 2010,55(17) :4933-4947.
  • 6Diaz-L6pez R, Tsapis N, Fattal E. Liquid perf|uorocarbons as contrast agents for ultrasonography and (19) F-MRI. Pharm Res, 2010,27(1):1-16.
  • 7Ragde H, Kenny GM, Murphy GP, et al. Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate,1997,32 (4) : 279-283.
  • 8Rapoport NY, Efros AL, Christensen DA, et al. Microbubble Generation in Phase-Shift Nanoemulsions used as Anticancer Drug Carriers. Bubble Sci Eng Technol, 2009,1(1-2):31 39.
  • 9Pisani E, Tsapis N, Paris J, et al. Polymeric'nano/microcap- sules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir, 2006,22(9) :4397-4402.
  • 10Kripfgans OD, Fowlkes JB, Miller DL, et al. Acoustic droplet vaporization for therapeutic and diagnostic applications. Ultra- sound Med Biol, 2000,26(7) : 1177-1189.

引证文献11

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部